HUSCAP logo Hokkaido Univ. logo

Hokkaido University Collection of Scholarly and Academic Papers >
Institute for Genetic Medicine >
Peer-reviewed Journal Articles, etc >

KRAS, MYC, and ARF6 : inseparable relationships cooperatively promote cancer malignancy and immune evasion

This item is licensed under:Creative Commons Attribution 4.0 International

Files in This Item:
Cell Commun Signal 21 106.pdf1.5 MBPDFView/Open
Please use this identifier to cite or link to this item:http://hdl.handle.net/2115/90514

Title: KRAS, MYC, and ARF6 : inseparable relationships cooperatively promote cancer malignancy and immune evasion
Authors: Sabe, Hisataka Browse this author →KAKEN DB
Keywords: AMAP1
ARF6
Cancer immune evasion
Cancer malignancy
eIF4A
KRAS
MYC
Mitochondria
mTOR
G-quadruplex structure
TP53
Issue Date: 8-May-2023
Publisher: BioMed Central
Journal Title: Cell Communication and Signaling
Volume: 21
Issue: 1
Start Page: 106
Publisher DOI: 10.1186/s12964-023-01130-3
Abstract: Mutations in the KRAS gene and overexpression of protein products of the MYC and ARF6 genes occur frequently in cancer. Here, the inseparable relationships and cooperation of the protein products of these three genes in cancer malignancy and immune evasion are discussed. mRNAs encoded by these genes share the common feature of a G-quadruplex structure, which directs them to be robustly expressed when cellular energy production is increased. These three proteins are also functionally inseparable from each other, as follows. 1) KRAS induces MYC gene expression, and may also promote eIF4A-dependent MYC and ARF6 mRNA translation, 2) MYC induces the expression of genes involved in mitochondrial biogenesis and oxidative phosphorylation, and 3) ARF6 protects mitochondria from oxidative injury. ARF6 may moreover promote cancer invasion and metastasis, and also acidosis and immune checkpoint. Therefore, the inseparable relationships and cooperation of KRAS, MYC, and ARF6 appear to result in the activation of mitochondria and the driving of ARF6-based malignancy and immune evasion. Such adverse associations are frequent in pancreatic cancer, and appear to be further enhanced by TP53 mutations.
Rights: http://creativecommons.org/licenses/by/4.0/
Type: article
URI: http://hdl.handle.net/2115/90514
Appears in Collections:遺伝子病制御研究所 (Institute for Genetic Medicine) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)

Submitter: 佐邊 壽孝

Export metadata:

OAI-PMH ( junii2 , jpcoar_1.0 )

MathJax is now OFF:


 

 - Hokkaido University